An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence

Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma

NCT06606028 ·Status: RECRUITING

Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers

NCT00899769 ·Status: COMPLETED

Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

NCT06678724 ·Status: RECRUITING

Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer

NCT00897052 ·Status: COMPLETED

Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck

NCT06744296 ·Status: RECRUITING

Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

NCT00896675 ·Status: COMPLETED

DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer

NCT00898664 ·Status: COMPLETED

Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

NCT00230308 ·Status: RECRUITING

Microbiome in Head and Neck Squamous Cell Carcinoma

NCT05837221 ·Status: RECRUITING

Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

NCT00898430 ·Status: TERMINATED

Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer

NCT02879968 ·Status: COMPLETED

Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer

NCT00908739 ·Status: WITHDRAWN

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202

NCT01503619 ·Status: COMPLETED

HNSCC Immuno-genomics Project

NCT06725342 ·Status: COMPLETED

Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx

NCT00899340 ·Status: COMPLETED

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

NCT01487733 ·Status: COMPLETED

Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma

NCT01374672 ·Status: COMPLETED

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

NCT06163534 ·Status: RECRUITING

Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva

NCT05122507 ·Status: UNKNOWN

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

NCT00898742 ·Status: TERMINATED

Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00898911 ·Status: COMPLETED

Family Study of Head and Neck Cancers in Taiwan

NCT00342147 ·Status: COMPLETED

Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer

NCT00899704 ·Status: WITHDRAWN

Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT04099290 ·Status: RECRUITING

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

NCT07149207 ·Status: RECRUITING ·Phase: PHASE2